Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thiophenes

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with thiophenes in 17 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(thiophenes)
Trials
(thiophenes)
Recent Studies (post-2010) (thiophenes)
9,15618755217,0121,9618,038

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19908 (47.06)18.7374
1990's6 (35.29)18.2507
2000's0 (0.00)29.6817
2010's3 (17.65)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crowley, H; Flynn, T; Maresca, C; Mason, C; O'Donnell, M; Walser, A; Yaremko, B1
Crowley, H; Flynn, T; Maresca, C; Mason, C; O'Donnell, M; Walser, A1
Hsueh, W; Needleman, P; Spaethe, SM1
Aiello, F; Musiani, P; Patrignani, P; Valitutti, S1
Dunn, MJ; Wang, J1
Hwang, SB; Lam, MH1
Aurousseau, M; Benveniste, J; Chignard, M; Greiss, M; Lalau Keraly, C; Maamer, M1
Maruyama, Y; Mikashima, H; Tahara, T; Terasawa, M1
Benveniste, J; Chignard, M; Delabassee, D; Delautier, D; Lalau Keraly, C1
Conard, J; Horellou, MH; Lecrubier, C; Samama, M1
Conroy, MC; Finkel, M; Grabow, D; Lesch, M; Low, J; Metz, A; Schrier, D; Sommers, C; Wallace, J1
Iizuka, Y; Itoh, K; Mukaiyama, O; Satoh, Y; Yamaguchi, T1
Cheon, SH; Handley, DA; Houlihan, WJ; Larson, DA; Parrino, VA1
Alaei, P; MacNulty, EE; Ryder, NS1
Antman, EM; Braunwald, E; Costigan, TM; Frelinger, AL; Jakubowski, JA; McCabe, CH; Michelson, AD; Miller, DL; Neumann, FJ; Trenk, D; Wiviott, SD1
Boyce, JA; Laidlaw, TM1
Chatziralli, IP; Demopoulos, CA; Moschos, MM; Papakonstantinou, VD; Stamatakis, G; Tsatsos, M1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thiophenes

ArticleYear
Platelets in patients with aspirin-exacerbated respiratory disease.
    The Journal of allergy and clinical immunology, 2015, Volume: 135, Issue:6

    Topics: Animals; Aspirin; Asthma, Aspirin-Induced; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Movement; Clinical Trials as Topic; Eosinophils; Gene Expression; Humans; Leukotrienes; Oxazoles; Piperazines; Platelet Activating Factor; Platelet Activation; Prasugrel Hydrochloride; Receptors, Leukotriene; Thiophenes; Thromboxane A2

2015

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thiophenes

ArticleYear
Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44.
    Thrombosis and haemostasis, 2011, Volume: 106, Issue:2

    Topics: Adenosine Diphosphate; Aged; Clopidogrel; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Ticlopidine

2011

Other Studies

15 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thiophenes

ArticleYear
Triazolobenzo- and triazolothienodiazepines as potent antagonists of platelet activating factor.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:3

    Topics: Animals; Azepines; Benzodiazepines; Blood Platelets; Bronchoconstriction; Chemical Phenomena; Chemistry; Dogs; Guinea Pigs; Male; Molecular Conformation; Molecular Structure; Platelet Activating Factor; Structure-Activity Relationship; Thiophenes; Triazoles

1991
Thienotriazolodiazepines as platelet-activating factor antagonists. Steric limitations for the substituent in position 2.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:4

    Topics: Animals; Azepines; Guinea Pigs; Indicators and Reagents; Lung; Magnetic Resonance Spectroscopy; Molecular Structure; Platelet Activating Factor; Structure-Activity Relationship; Thiophenes; Triazoles

1991
Pharmacological manipulation of inflammation in rabbit hydronephrosis: effects of a combined cyclooxygenase/lipoxygenase inhibitor ethoxyquin, a thromboxane synthase inhibitor RS-5186 and a PAF antagonist L-659,989.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 248, Issue:3

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Ethoxyquin; Fatty Acids, Nonesterified; Furans; Hydronephrosis; Inflammation; Kidney; Leukotriene B4; Lipoxygenase Inhibitors; Male; Perfusion; Platelet Activating Factor; Quinolines; Rabbits; Thiophenes; Thromboxane-A Synthase

1989
Platelet-activating factor (PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferation.
    Biochemical and biophysical research communications, 1987, Oct-29, Volume: 148, Issue:2

    Topics: Cells, Cultured; DNA Replication; Furans; Humans; Kinetics; Lymphocyte Activation; Monocytes; Phytohemagglutinins; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; T-Lymphocytes; Thiophenes

1987
Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats.
    The American journal of physiology, 1987, Volume: 253, Issue:6 Pt 2

    Topics: Acute Kidney Injury; Animals; Endotoxins; Female; Furans; Glomerular Filtration Rate; Kidney; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Regional Blood Flow; Thiophenes

1987
Species difference in the specific receptors of platelet activating factor.
    Biochemical pharmacology, 1986, Dec-15, Volume: 35, Issue:24

    Topics: Animals; Benzofurans; Blood Platelets; Cell Membrane; Diterpenes; Furans; Ginkgolides; Humans; Lactones; Lignans; Lung; Phospholipid Ethers; Plant Extracts; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Species Specificity; Thiazoles; Thiophenes

1986
Inhibitory effects of three new synthetic compounds on human platelet aggregation.
    Thrombosis research, 1986, Nov-15, Volume: 44, Issue:4

    Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Humans; Kinetics; Platelet Activating Factor; Platelet Aggregation; Structure-Activity Relationship; Thiophenes; Thrombin

1986
PAF antagonistic activity of some thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines.
    Chemical & pharmaceutical bulletin, 1987, Volume: 35, Issue:5

    Topics: Azepines; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation; Thiophenes; Triazoles

1987
Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets.
    Thrombosis research, 1984, Jun-15, Volume: 34, Issue:6

    Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Humans; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thiophenes; Ticlopidine

1984
Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin.
    Agents and actions, 1983, Volume: 13, Issue:1

    Topics: Adult; Aged; Anticoagulants; Aspirin; Epinephrine; Humans; In Vitro Techniques; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Thiophenes; Ticlopidine

1983
Cytoprotective effects of CI-959 in the rat gastric mucosa: modulation of leukocyte adhesion.
    Gastroenterology, 1995, Volume: 109, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Cell Adhesion; Dinoprostone; Dogs; Ethanol; Female; Gastric Acid; Gastric Mucosa; Histamine Antagonists; Indomethacin; Leukocytes; Leukotriene C4; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sulfhydryl Compounds; Tetrazoles; Thiophenes

1995
Effects of CS-518, a thromboxane synthase inhibitor, on eosinophil function.
    European journal of pharmacology, 1993, Aug-03, Volume: 239, Issue:1-3

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemotaxis, Leukocyte; Eosinophils; Epoprostenol; Guinea Pigs; In Vitro Techniques; Male; Peroxidases; Platelet Activating Factor; Pulmonary Alveoli; Superoxides; Thiophenes; Thromboxane A2; Thromboxane-A Synthase

1993
Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists.
    Journal of medicinal chemistry, 1993, Oct-15, Volume: 36, Issue:21

    Topics: Animals; Binding, Competitive; Bronchoconstriction; Guinea Pigs; Humans; Isoquinolines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Thienopyridines; Thiophenes

1993
Inhibition of protein prenylation down-regulates signalling by inflammatory mediators in human keratinocytes.
    Biochemical and biophysical research communications, 1996, May-06, Volume: 222, Issue:1

    Topics: Adenosine Triphosphate; Benzylamines; Bradykinin; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Inositol 1,4,5-Trisphosphate; Keratinocytes; Mevalonic Acid; Platelet Activating Factor; Protein Prenylation; Signal Transduction; Thiophenes; Thrombin

1996
In Vitro Effects of Anti-Glaucomatous Eye Drops on Platelet-Activating Factor and its Metabolism.
    Seminars in ophthalmology, 2017, Volume: 32, Issue:2

    Topics: Animals; Disease Models, Animal; Drug Combinations; Glaucoma; Intraocular Pressure; Ophthalmic Solutions; Platelet Activating Factor; Platelet Aggregation; Rabbits; Sulfonamides; Thiophenes; Timolol

2017